Daniel John O'Shannessy

Title: The Innovative Contributions of Daniel John O'Shannessy

Introduction

Daniel John O'Shannessy is a notable inventor based in Schwenksville, Pennsylvania. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic antibodies. With a total of 10 patents to his name, O'Shannessy's work has the potential to impact cancer diagnosis and treatment.

Latest Patents

Among his latest patents is the development of anti-folate receptor alpha antibodies and their uses. This patent describes antibodies and antigen-binding fragments that are specific for folate receptor alpha. It also includes related polynucleotides, expression vectors, and cells that express these antibodies. The methods provided involve diagnosing folate receptor alpha-expressing cancers by determining the amount of folate receptor alpha in a sample and comparing it with a control sample. Another significant patent is for TEM-1 diagnostic antibodies, which are specific for tumor endothelial marker 1 (TEM-1). This patent outlines methods for diagnosing TEM-1-expressing cancers, such as melanoma and colon cancer, by measuring the amount of TEM-1 in biological samples.

Career Highlights

O'Shannessy has worked with prominent companies in the biotechnology sector, including Eisai R&D Management Co., Ltd. and Morphotek, Inc. His experience in these organizations has contributed to his expertise in developing innovative diagnostic tools.

Collaborations

Throughout his career, O'Shannessy has collaborated with notable colleagues, including Elizabeth B. Somers and Nicholas C. Nicolaides. These collaborations have likely enhanced his research and development efforts in the field of cancer diagnostics.

Conclusion

Daniel John O'Shannessy is a distinguished inventor whose work in developing diagnostic antibodies has the potential to revolutionize cancer detection and treatment. His contributions to biotechnology are significant and continue to influence the field.